…e in DSS-induced murine model (IDDF2026-ABS-0190 Figure 1(A-F)).Phytosphingosine(PHS) was identified as the specific active component in FPEVs b…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 425 of 2459…ng intratumoral microbial community composition. Advanced-stage CRC exhibited significantly higher microbial α-diversity, a more co…
…ted with metachronous recurrence following ESD in patients with superficial esophageal squamous cell carcinoma and precancerous lesions, with the goal of developing a nomogra…
…y clinical diagnosis).Pre-treatment FRS significantly predicted infliximab non-response (responders: -0.078±0.394 vs non-responders: 0.599…
…D. Patients with the lowest immune infiltration respond best to infliximab, while pan-immune activated patients, driven principally by mon…
…ection and local ablation are important curative treatments for hepatocellular carcinoma. However, the 5-year recurrence rate after ablation can reach 7…
…d to eubiotic counterparts (IDDF2026-ABS-0279 Figure 3. Chronic aspartame exposure drives disrupted microbial homeostasis and Enterococcu…
…ng to senescence escape. Pharmacological targeting of M7CK with MK-1602 (a novel inhibitor identified by virtual screening, KD = 6.49 μ…
…rine insufficiency (PEI) has been linked to an elevated risk of fatty liver disease. However, its relationship with metabolic dysfunction-associate…
…d deaths.Conclusions The LiverHealth score accurately predicted liver fibrosis and LREs in community-dwelling adults. These findings support u…
…pylori treatment, with their CATEs aggregated into the PTBS. In MITS, targeting the high-treatment-benefit subgroup reduced GC risk …
…round Barrett’s esophagus (BE) increases the risk of developing esophageal adenocarcinoma. Over 90% of BE cases are non-dysplastic BE (NDBE). Spatialomic…